Real-time
BOERSE MUENCHEN
15:14:17 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
1.58
EUR
|
-2.47%
|
|
-2.41%
|
-2.99%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,324
|
3,647
|
347.4
|
157.7
|
137.6
|
-
|
-
|
Enterprise Value (EV)
1 |
3,324
|
3,093
|
-149
|
157.7
|
137.6
|
137.6
|
137.6
|
P/E ratio
|
44.5
x
|
-22.6
x
|
-0.99
x
|
-0.82
x
|
-1.19
x
|
-1.57
x
|
-1.28
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
14.1
x
|
264
x
|
-10.8
x
|
40.5
x
|
183
x
|
183
x
|
138
x
|
EV / Revenue
|
14.1
x
|
264
x
|
-10.8
x
|
40.5
x
|
183
x
|
183
x
|
138
x
|
EV / EBITDA
|
126,766,580
x
|
-11,718,912
x
|
-1,296,513
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
50.6
x
|
-24
x
|
-2.09
x
|
-0.87
x
|
-1.81
x
|
-1.7
x
|
-1.56
x
|
FCF Yield
|
1.98%
|
-4.16%
|
-47.8%
|
-115%
|
-55.3%
|
-58.7%
|
-64.1%
|
Price to Book
|
8.95
x
|
11.5
x
|
1.83
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
70,496
|
76,963
|
83,099
|
82,991
|
80,702
|
-
|
-
|
Reference price
2 |
47.15
|
47.39
|
4.180
|
1.900
|
1.705
|
1.705
|
1.705
|
Announcement Date
|
21-03-29
|
22-03-29
|
23-03-31
|
24-03-14
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4.226
|
235.8
|
13.81
|
-32.12
|
3.893
|
0.75
|
0.75
|
1
|
EBITDA
|
-205.6
|
26.22
|
-311.2
|
-267.9
|
-
|
-
|
-
|
-
|
EBIT
1 |
-206.4
|
23.78
|
-325.1
|
-271.7
|
-174.1
|
-151.6
|
-160.3
|
-169.8
|
Operating Margin
|
-4,883.22%
|
10.08%
|
-2,353.06%
|
845.79%
|
-4,471.87%
|
-20,209.02%
|
-21,374.43%
|
-16,978.18%
|
Earnings before Tax (EBT)
1 |
-204.5
|
73.86
|
-366.4
|
-349.6
|
-206.4
|
-143.3
|
-146.4
|
-168.4
|
Net income
1 |
-209.2
|
71.99
|
-365.9
|
-349.7
|
-206.4
|
-143.3
|
-146.4
|
-168.4
|
Net margin
|
-4,950%
|
30.53%
|
-2,648.7%
|
1,088.53%
|
-5,302.83%
|
-19,106.37%
|
-19,515.09%
|
-16,844.84%
|
EPS
2 |
-65.39
|
1.060
|
-2.095
|
-4.240
|
-2.330
|
-1.436
|
-1.084
|
-1.328
|
Free Cash Flow
1 |
-124.3
|
65.69
|
-151.8
|
-166.2
|
-181.9
|
-76.1
|
-80.8
|
-88.2
|
FCF margin
|
-2,942.09%
|
27.85%
|
-1,098.7%
|
517.38%
|
-4,671.26%
|
-10,146.67%
|
-10,773.33%
|
-8,820%
|
FCF Conversion (EBITDA)
|
-
|
250.52%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
91.25%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-03-31
|
21-03-29
|
22-03-29
|
23-03-31
|
24-03-14
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
-
|
235.8
|
2.753
|
4.874
|
5.316
|
11.02
|
3.597
|
3.597
|
7.742
|
-39.87
|
2.711
|
1.182
|
-
|
-
|
0.75
|
-
|
-
|
0.75
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-86.86
|
117.6
|
-159
|
-67.63
|
-73.77
|
-163.9
|
-56.91
|
-56.91
|
-122.5
|
-149.2
|
-92.64
|
-81.45
|
-43.78
|
-45.17
|
-85.26
|
-47.25
|
-48.2
|
-84.68
|
-48.64
|
-
|
-
|
Operating Margin
|
-
|
49.86%
|
-5,776.17%
|
-1,387.67%
|
-1,387.67%
|
-1,486.94%
|
-1,582.07%
|
-1,582.07%
|
-1,582.16%
|
374.28%
|
-3,417.23%
|
-6,890.78%
|
-
|
-
|
-11,368.4%
|
-
|
-
|
-11,291.07%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-82.5
|
163
|
-167.2
|
-87.06
|
-94.96
|
-197
|
-72.62
|
-72.62
|
-156.3
|
-
|
-106.6
|
-99.87
|
-43.78
|
-45.17
|
-78.54
|
-47.25
|
-48.2
|
-65.63
|
-48.64
|
-54.21
|
-54.21
|
Net income
1 |
-82.5
|
161.1
|
-166.7
|
-87.06
|
-94.96
|
-197
|
-72.62
|
-72.62
|
-156.3
|
-
|
-106.6
|
-99.87
|
-43.78
|
-45.17
|
-78.54
|
-47.25
|
-48.2
|
-65.63
|
-48.64
|
-54.21
|
-54.21
|
Net margin
|
-
|
68.31%
|
-6,056.12%
|
-1,786.31%
|
-1,786.31%
|
-1,786.54%
|
-2,018.63%
|
-2,018.63%
|
-2,018.75%
|
-
|
-3,931.13%
|
-8,448.9%
|
-
|
-
|
-10,472.18%
|
-
|
-
|
-8,750.1%
|
-
|
-
|
-
|
EPS
2 |
-1.558
|
2.618
|
-2.280
|
-1.110
|
-1.211
|
-1.094
|
-0.8837
|
-0.8837
|
-1.900
|
-2.340
|
-1.280
|
-1.050
|
-0.2200
|
-0.2240
|
-0.5455
|
-0.2320
|
-0.2350
|
-0.4820
|
-0.2330
|
-0.2490
|
-0.2490
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-08-31
|
21-03-29
|
21-08-31
|
22-11-10
|
22-03-29
|
22-03-29
|
22-11-10
|
22-08-30
|
22-08-30
|
23-03-31
|
23-08-17
|
24-03-14
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
554
|
496
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-124
|
65.7
|
-152
|
-166
|
-182
|
-76.1
|
-80.8
|
-88.2
|
ROE (net income / shareholders' equity)
|
-95.8%
|
26.2%
|
-45.6%
|
-9.24%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-70.6%
|
11.7%
|
-39%
|
-7.23%
|
-
|
-
|
-
|
-
|
Assets
1 |
296.3
|
616.9
|
938.7
|
4,837
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-82.90
|
5.270
|
4.130
|
2.280
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-38.80
|
0.4300
|
-0.8400
|
-0.8400
|
-
|
-
|
-
|
-
|
Capex
1 |
1.73
|
1.24
|
4.53
|
6.63
|
1.57
|
-
|
-
|
-
|
Capex / Sales
|
40.93%
|
0.52%
|
32.79%
|
-20.64%
|
40.28%
|
-
|
-
|
-
|
Announcement Date
|
20-03-31
|
21-03-29
|
22-03-29
|
23-03-31
|
24-03-14
|
-
|
-
|
-
|
Last Close Price
1.705
USD Average target price
7.25
USD Spread / Average Target +325.22% Consensus |
1st Jan change
|
Capi.
|
---|
| +55.14% | 811B | | +43.62% | 640B | | -7.13% | 353B | | +18.47% | 333B | | +8.98% | 302B | | +16.30% | 246B | | +2.41% | 225B | | +12.47% | 218B | | +8.49% | 168B |
Other Pharmaceuticals
|